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ABSTRACT 
AIM OF THE STUDY: 
1. To estimate the levels of bilirubin and albumin in cord blood. 
2. To estimate the relationship between cord blood bilirubin and occurrence 
of neonatal hyperbilirubinemia. 
3. To estimate the relationship between cord blood albumin and occurrence 
of neonatal hyperbilirubinemia. 
METHODOLOGY: 
This prospective study was conducted in Rajah Mirasudhar Hospital, attached to 
Thanjavur Medical College, Thanjavur, during the period of Feburary 2017 to July2017. 
The study sample consisted of 55 healthy term newborn babies with blood group O+ve 
born to O+ve mothers as control and 37 healthy term newborns with blood group A+ve  
or  B+ve  born to O+ve mothers as case group. 
Umbilical cord blood was collected from newborns and serum albumin and bilirubin 
levels estimated. Relevant history was obtained from mother and maternal hospital 
records. The babies were followed-up daily for development of jaundice and serum 
bilirubin was measured in all newborns at 24 and 72 hours of life.  
RESULTS 
 The mean serum total bilirubin in umbilical cord blood was 1.596+0.46 mg/dl 
in control group and 1.995+1.16 mg/dl in case group. 
 The umbilical cord serum albumin and total bilirubin correlates well with the 
development of significant neonatal hyperbilirubinemia requiring treatment 
in the form of phototherapy with or without exchange transfusion. 
 Umbilical cord serum albumin level of less than or equal to 3.15 g/dl predicts 
the development of significant hyperbilirubinemia with a sensitivity of 
76.5%, specificity of 78.7% and an accuracy of 77.6%. The accuracy of 
prediction of significant hyperbilirubinemia by cord serum albumin is higher 
for babies with ABO incompatibility when compared with control group. 
 Umbilical cord serum total bilirubin of more than or equal to1.85 mg/dl 
predicts the development of significant hyperbilirubinemia with a sensitivity 
of 70.6%, specificity of 82.7% and an accuracy of 76.7%. 
CONCLUSION 
 In ABO blood group incompatibility, neonates with umbilical cord blood 
total bilirubin >1.85 mg/dl and albumin <3.15 g/dl need close follow up to 
watch for development of hyperbilirubinemia while those babies with 
umbilical cord total bilirubin <1.85 mg/dl and albumin>3.15 g/dl can be 
safely discharged early.  
   Hence, we recommend routine measurement of serum bilirubin and albumin 
levels in umbilical cord blood at birth to predict those newborns at risk of 
developing significant hyperbilirubinemia requiring treatment in the form of 
phototherapy with or without exchange transfusion. 
 
 
